Understanding metastasis mixed-treatment responses through genomic analyses

Understanding metastasis mixed-treatment responses through genomic analyses

Abstract Early-stage and metastatic breast cancers (MBC) can exhibit genomic heterogeneity, even within the same individual. Response to therapy in metastatic breast cancer patients with multiple metastases can also be heterogeneous, with different degrees of responsiveness to the same drug(s) acros...

Full description

Saved in:
Bibliographic Details
Main Authors: Susana Garcia-Recio, Paola Zagami, Brooke M. Felsheim, Amy Wheless, Kerry Thomas, Renato Trimarchi, Lisa A. Carey, Charles M. Perou
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-025-00724-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items